Salarius Pharmaceuticals, Inc.
USD0.84
+0.19 (+29.23%)
CEO
Frederick E. Pierce
IPO Date
2015-01-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.71
Prev. Close
$0.65
Day Low
$0.69
Day High
$0.90
52W Low
$0.52
52W High
$52.95
Market Cap
$0.00B
Volume
5.96M
| $0.64 |
| 24 Nov 2025 | HANISH ARNOLD C | director | P-Purchase | Acquired | 5,000 | $0.75 |
| 24 Nov 2025 | Marschel Peter Klaus | Chief Business Officer | Disposed | 50,619 | $0.00 |
| 24 Nov 2025 | Marschel Peter Klaus | Chief Business Officer | Disposed | 5,061 | $4.94 |
| 24 Nov 2025 | Marschel Peter Klaus | Chief Business Officer | Disposed | 8,318 | $50.26 |
| 24 Nov 2025 | Hibner Barbara Louise | Chief Scientific Officer | Disposed | 50.619 | $0.00 |
| 24 Nov 2025 | Hibner Barbara Louise | Chief Scientific Officer | Disposed | 5,061 | $4.94 |
| 24 Nov 2025 | Hibner Barbara Louise | Chief Scientific Officer | Disposed | 8,318 | $50.26 |
| 24 Nov 2025 | PIERCE FREDERICK II | Chief Executive Office | Disposed | 0 | $0.00 |